Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Fibrin Sealant and Lipoabdominoplasty in Obese Grade 1 and 2 Patients

View through CrossRef
Background Ever since lipoabdominoplasty was first developed to achieve better aesthetic outcomes and less morbidity, the rate of seroma formation, especially in obese patients, has disturbed plastic surgeons. The aim of this study was to evaluate the effect of fibrin sealant in the prevention of seroma formation after lipoabdominoplasty in obese patients. Methods Sixty patients with a body mass index (BMI) between 30 and 39.9 were assigned randomly to 1 of 2 groups (30 patients each). Group A underwent lipoabdominoplasty with fibrin glue, while group B underwent traditional lipoabdominoplasty; both had closed suction drainage applied to the abdomen. The patients' demographics and postoperative complications were recorded. Seroma was detected using abdominal ultrasound examinations at two postoperative periods: between postoperative days 10 and 12 and, between postoperative days 18 and 21. Results The age range was 31 to 55 years (38.5±9.5 years) in group A and 25 to 58 years (37.8±9.1 years) in group B, while the mean BMI was 31.4 to 39.9 kg/m2 (32.6 kg/m2) in group A and 32.7 to 37.4 kg/m2 (31.5 kg/m2) in group B. In group A, the patients had a complication rate of 10% in group A versus 43% in group B (P<0.05). The incidence of seroma formation was 3% in the fibrin glue group but 37% in the lipoabdominoplasty-alone group (P<0.05). Conclusions Lipoabdominoplasty with the use of autologous fibrin sealant is a very effective method that significantly reduces the rate of postoperative seroma.
Title: Fibrin Sealant and Lipoabdominoplasty in Obese Grade 1 and 2 Patients
Description:
Background Ever since lipoabdominoplasty was first developed to achieve better aesthetic outcomes and less morbidity, the rate of seroma formation, especially in obese patients, has disturbed plastic surgeons.
The aim of this study was to evaluate the effect of fibrin sealant in the prevention of seroma formation after lipoabdominoplasty in obese patients.
Methods Sixty patients with a body mass index (BMI) between 30 and 39.
9 were assigned randomly to 1 of 2 groups (30 patients each).
Group A underwent lipoabdominoplasty with fibrin glue, while group B underwent traditional lipoabdominoplasty; both had closed suction drainage applied to the abdomen.
The patients' demographics and postoperative complications were recorded.
Seroma was detected using abdominal ultrasound examinations at two postoperative periods: between postoperative days 10 and 12 and, between postoperative days 18 and 21.
Results The age range was 31 to 55 years (38.
5±9.
5 years) in group A and 25 to 58 years (37.
8±9.
1 years) in group B, while the mean BMI was 31.
4 to 39.
9 kg/m2 (32.
6 kg/m2) in group A and 32.
7 to 37.
4 kg/m2 (31.
5 kg/m2) in group B.
In group A, the patients had a complication rate of 10% in group A versus 43% in group B (P<0.
05).
The incidence of seroma formation was 3% in the fibrin glue group but 37% in the lipoabdominoplasty-alone group (P<0.
05).
Conclusions Lipoabdominoplasty with the use of autologous fibrin sealant is a very effective method that significantly reduces the rate of postoperative seroma.

Related Results

Corroboration Development and Regulatory approval of Fibrin Sealant
Corroboration Development and Regulatory approval of Fibrin Sealant
Objective Finding the relation between scientific evidence development and regulatory approval of medical devices in existing markets, USA (United states of America) and EU (...
Fibrin sealants in lumbar annuloplasty after endoscopic discectomy as a method to prevent recurrent lumbar disc herniation
Fibrin sealants in lumbar annuloplasty after endoscopic discectomy as a method to prevent recurrent lumbar disc herniation
 Fibrin sealant as a promising agent for providing scaffold and efficient hemostasis is widely accepted in several specialties. However, the outcome of Fibrin sealants in lumbar an...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Lipoabdominoplasty with Anatomical Definition
Lipoabdominoplasty with Anatomical Definition
Background: In the past two decades, lipoabdominoplasty has increased in popularity worldwide, presenting low rates of complications and morbidity when the proper surgi...
Advancing Well Integrity: Petronas’ First Application of Time-Activated Sealant Technology
Advancing Well Integrity: Petronas’ First Application of Time-Activated Sealant Technology
Abstract Background and Scope Within aging brownfields, maintaining the integrity of wellheads and control lines presents a prev...
2109. Liposomal Amphotericin B-associated Nephrotoxicity in Obese and Non-obese Patients
2109. Liposomal Amphotericin B-associated Nephrotoxicity in Obese and Non-obese Patients
Abstract Background Liposomal amphotericin B (L-amb) is an important antifungal agent which exhibits significant rates of dose-d...
The Rise of Obesity among Total Knee Arthroplasty Patients
The Rise of Obesity among Total Knee Arthroplasty Patients
AbstractIn the United States, one-third of adults are considered obese, and demand for total knee arthroplasty (TKA) is expected to rise in these patients. Surgeons are reluctant t...

Back to Top